First-pass extracted concept

glioblastoma stem cells

Candidate: concept label1 source documents7 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

GSCs

Extracted Explainers

What the tool is doing

The review presents glioblastoma stem cells as a stem-like population at the apex of glioblastoma cellular hierarchy. They are discussed as functionally distinct from differentiated tumor progeny.

Source 1DOIPubMed

What problem it solves

This concept helps explain tumor growth, heterogeneity, and variable response to therapy in glioblastoma.

Source 1DOIPubMed

What it does not solve

The abstract does not support a single universal marker or therapy for GSCs, and it explicitly notes that purification and characterization remain difficult.

Source 1DOIPubMed

Alternatives

The review contrasts GSC-focused interpretation with reliance on inferior cell lines and insufficient functional analyses.

Source 1DOIPubMed

Evidence Snippets

Glioblastomas display striking cellular heterogeneity, with stem-like glioblastoma stem cells (GSCs) at the apex.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1functional rolesupports2019Source 1DOIPubMed

Evidence has grown that glioblastoma stem cells play important roles in tumor growth and response to therapy.

Claim 2heterogeneity mechanismsupports2019Source 1DOIPubMed

Glioblastoma stem cells are functionally defined and distinguished from differentiated tumor progeny at transcriptional, epigenetic, and metabolic regulatory levels.

Claim 3hierarchy modelsupports2019Source 1DOIPubMed

Glioblastomas display cellular heterogeneity with glioblastoma stem cells at the apex of a tumor hierarchy.

Claim 4immunology contextsupports2019Source 1DOIPubMed

Glioblastomas induce systemic immunosuppression and show mixed responses to oncoimmunologic modalities, suggesting response may be augmented by deeper consideration of glioblastoma stem cells.

Claim 5literature quality limitationsupports2019Source 1DOIPubMed

The glioblastoma stem cell literature is complicated by frequent use of inferior cell lines and lack of proper functional analyses.

Claim 6technical challengesupports2019Source 1DOIPubMed

Purification and characterization of glioblastoma stem cells remain challenging.

Claim 7therapeutic implicationsupports2019Source 1DOIPubMed

No single therapeutic modality is likely to be universally effective against a heterogeneous glioblastoma stem cell population.